| NCT04322240 |
Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT04322240 |
Recruiting |
Benha University |
2020-07-15 |
| NCT03252132 |
Resistance Training in Patients With Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT03252132 |
Recruiting |
Danish Pain Research Center |
2018-12-31 |
| NCT03050827 |
Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT03050827 |
Completed |
Eastern Virginia Medical School |
2017-08-17 |
| NCT03008733 |
Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG |
https://ClinicalTrials.gov/show/NCT03008733 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2018-12-31 |
| NCT02871284 |
Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training |
https://ClinicalTrials.gov/show/NCT02871284 |
Completed |
German Cancer Research Center |
2019-07-31 |
| NCT02595983 |
The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant |
https://ClinicalTrials.gov/show/NCT02595983 |
Completed |
Alnylam Pharmaceuticals |
2017-02-06 |
| NCT02027701 |
Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
https://ClinicalTrials.gov/show/NCT02027701 |
Completed |
CSL Behring |
2017-07-10 |
| NCT02341261 |
Activity for Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT02341261 |
Recruiting |
Virginia Commonwealth University |
2022-04-30 |
| NCT02260388 |
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations |
https://ClinicalTrials.gov/show/NCT02260388 |
Completed |
University of Kansas Medical Center |
2017-09-30 |
| NCT02191826 |
Study of SOM0226 in Familial Amyloid Polyneuropathy |
https://ClinicalTrials.gov/show/NCT02191826 |
Completed |
SOM Biotech SL |
2015-11-30 |
| NCT02175004 |
Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) |
https://ClinicalTrials.gov/show/NCT02175004 |
Active, not recruiting |
Ionis Pharmaceuticals, Inc. |
2022-06-30 |
| NCT02129231 |
Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT02129231 |
Completed |
University of Guadalajara |
2014-01-31 |
| NCT02121678 |
Effect of Resistance and Aerobic Exercise in CIDP or MMN |
https://ClinicalTrials.gov/show/NCT02121678 |
Completed |
University of Aarhus |
2015-12-31 |
| NCT02107469 |
A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy |
https://ClinicalTrials.gov/show/NCT02107469 |
Completed |
Rosenberg European Academy of Ayurveda |
2016-02-29 |
| NCT02045199 |
Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy. |
https://ClinicalTrials.gov/show/NCT02045199 |
Completed |
Pierre Fabre Medicament |
2015-03-31 |
| NCT01960348 |
APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis |
https://ClinicalTrials.gov/show/NCT01960348 |
Completed |
Alnylam Pharmaceuticals |
2017-08-31 |
| NCT01926522 |
Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT01926522 |
Completed |
Habilita, Ospedale di Sarnico |
2013-11-30 |
| NCT01824251 |
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. |
https://ClinicalTrials.gov/show/NCT01824251 |
Completed |
Nihon Pharmaceutical Co., Ltd |
2015-09-30 |
| NCT01737398 |
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy |
https://ClinicalTrials.gov/show/NCT01737398 |
Completed |
Ionis Pharmaceuticals, Inc. |
2017-03-03 |
| NCT01713426 |
A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment |
https://ClinicalTrials.gov/show/NCT01713426 |
Completed |
Astellas Pharma Inc |
2013-09-26 |
| NCT01622777 |
The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study |
https://ClinicalTrials.gov/show/NCT01622777 |
Completed |
University of Guadalajara |
2011-01-31 |
| NCT01607684 |
Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis |
https://ClinicalTrials.gov/show/NCT01607684 |
Completed |
Martin-Luther-Universität Halle-Wittenberg |
2012-09-30 |
| NCT01565317 |
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT01565317 |
Completed |
Joslin Diabetes Center |
2015-05-31 |
| NCT01545076 |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) |
https://ClinicalTrials.gov/show/NCT01545076 |
Completed |
CSL Behring |
2016-09-30 |
| NCT01465620 |
Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study |
https://ClinicalTrials.gov/show/NCT01465620 |
Completed |
Henri Mondor University Hospital |
2018-06-30 |
| NCT01450163 |
Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy |
https://ClinicalTrials.gov/show/NCT01450163 |
Completed |
University of Sao Paulo |
2014-10-31 |
| NCT01435655 |
The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin |
https://ClinicalTrials.gov/show/NCT01435655 |
Completed |
Pfizer |
2014-02-28 |
| NCT01370837 |
Neurogenic Inflammation in Diabetes |
https://ClinicalTrials.gov/show/NCT01370837 |
Completed |
Maastricht University Medical Center |
2015-01-31 |
| NCT01349270 |
Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg |
https://ClinicalTrials.gov/show/NCT01349270 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2013-12-31 |
| NCT01347671 |
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT01347671 |
Completed |
Grünenthal GmbH |
2012-01-31 |
| NCT04214665 |
To Assess the Bioequivalence of Test Oral Formulation of Alpha Lipoic Acid 600 mg HR Film Coated Tablets of Ilko Ilac San. Ve Tic. A.S. Versus Reference Thioctacid (Alpha Lipoic Acid) 600 mg HR Film Coated Tablets of Meda Pharma GmbH& CO .KG, Germany. |
https://ClinicalTrials.gov/show/NCT04214665 |
Completed |
Ilko Ilac San. ve Tic. A.S. |
2015-01-24 |
| NCT04136184 |
NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy |
https://ClinicalTrials.gov/show/NCT04136184 |
Recruiting |
Ionis Pharmaceuticals, Inc. |
2024-01-31 |
| NCT03765489 |
Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock |
https://ClinicalTrials.gov/show/NCT03765489 |
Completed |
University of Chile |
2018-06-21 |
| NCT03687840 |
Spatio-Temporal Gait Parameters and Gait Symmetry In Diabetic Lower Extremity Burn Injury. |
https://ClinicalTrials.gov/show/NCT03687840 |
Completed |
Recep Tayyip Erdogan University Training and Research Hospital |
2018-02-11 |
| NCT03684018 |
Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP |
https://ClinicalTrials.gov/show/NCT03684018 |
Active, not recruiting |
CSL Behring |
2022-08-31 |
| NCT03617185 |
Effect of Exercise and Surgical Weight Loss on Polyneuropathy |
https://ClinicalTrials.gov/show/NCT03617185 |
Recruiting |
University of Michigan |
2023-01-01 |
| NCT01263132 |
Neuropathic Pain Management |
https://ClinicalTrials.gov/show/NCT01263132 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-02-28 |
| NCT01184846 |
Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy |
https://ClinicalTrials.gov/show/NCT01184846 |
Completed |
CSL Behring |
2011-11-30 |
| NCT01079325 |
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT01079325 |
Completed |
Sangamo Therapeutics |
2015-05-31 |
| NCT01076478 |
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines |
https://ClinicalTrials.gov/show/NCT01076478 |
Completed |
Otsuka Pharmaceutical, Inc., Philippines |
NA |
| NCT01006915 |
Surgical Decompression for Diabetic Neuropathy in the Foot |
https://ClinicalTrials.gov/show/NCT01006915 |
Completed |
Timothy J. Best Medicine Professional Corporation |
2015-03-31 |
| NCT00993070 |
Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT00993070 |
Completed |
Thammasat University |
2011-12-31 |
| NCT00977483 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) |
https://ClinicalTrials.gov/show/NCT00977483 |
Completed |
MEDA Pharma GmbH & Co. KG |
2005-01-31 |
| NCT00962429 |
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00962429 |
Completed |
Oregon Health and Science University |
2013-01-31 |
| NCT00944697 |
A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00944697 |
Completed |
Mundipharma Research GmbH & Co KG |
2010-03-31 |
| NCT00927914 |
Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00927914 |
Completed |
Eisai Inc. |
2013-01-31 |
| NCT03870295 |
Technique to Measure Type C Fibre Nerve Conduction Velocitynerve Fibers in Polyneuropathies |
https://ClinicalTrials.gov/show/NCT03870295 |
Recruiting |
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
2020-09-29 |
| NCT00878293 |
Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic |
https://ClinicalTrials.gov/show/NCT00878293 |
Completed |
Grünenthal GmbH |
2010-05-31 |
| NCT01302275 |
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT01302275 |
Completed |
Odense University Hospital |
2013-05-31 |
| NCT00802022 |
Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00802022 |
Completed |
Maastricht University Medical Center |
2010-07-31 |
| NCT04281472 |
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) |
https://ClinicalTrials.gov/show/NCT04281472 |
Recruiting |
argenx BVBA |
2023-08-15 |
| NCT00791492 |
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00791492 |
Completed |
Pfizer |
2008-08-31 |
| NCT00759265 |
Improving Mobility in Diabetic Patients Through Resistance Training |
https://ClinicalTrials.gov/show/NCT00759265 |
Completed |
Maastricht University Medical Center |
2010-02-28 |
| NCT00716066 |
Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT00716066 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2026-03-31 |
| NCT00665145 |
Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509 |
https://ClinicalTrials.gov/show/NCT00665145 |
Completed |
Sangamo Therapeutics |
2009-10-31 |
| NCT00630864 |
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis |
https://ClinicalTrials.gov/show/NCT00630864 |
Completed |
Pfizer |
2010-01-31 |
| NCT00614562 |
Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M) |
https://ClinicalTrials.gov/show/NCT00614562 |
Completed |
University Hospital Inselspital, Berne |
2009-06-30 |
| NCT01251211 |
Botulinum Toxin in Peripheral Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT01251211 |
Completed |
Hospital Ambroise Paré Paris |
2014-01-31 |
| NCT00570310 |
Neuropathic Pain Syndrome Patient Study (MK-0000-072) |
https://ClinicalTrials.gov/show/NCT00570310 |
Completed |
Merck Sharp & Dohme Corp. |
2008-09-30 |
| NCT00539175 |
Treatment of Painful Diabetic Neuropathy With Photon Stimulation |
https://ClinicalTrials.gov/show/NCT00539175 |
Completed |
East Bay Institute for Research and Education |
NA |
| NCT00507936 |
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT00507936 |
Completed |
AbbVie |
2008-10-31 |
| NCT00501202 |
Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). |
https://ClinicalTrials.gov/show/NCT00501202 |
Completed |
SK Life Science, Inc. |
2008-05-31 |
| NCT00483730 |
Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) |
https://ClinicalTrials.gov/show/NCT00483730 |
Completed |
Nycomed |
2008-05-31 |
| NCT00476931 |
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT00476931 |
Completed |
Sangamo Therapeutics |
2010-07-31 |
| NCT00409175 |
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis |
https://ClinicalTrials.gov/show/NCT00409175 |
Completed |
Pfizer |
2009-05-31 |
| NCT00406458 |
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT00406458 |
Completed |
Sangamo Therapeutics |
2008-12-31 |
| NCT00328601 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) |
https://ClinicalTrials.gov/show/NCT00328601 |
Completed |
MEDA Pharma GmbH & Co. KG |
NA |
| NCT00307749 |
Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00307749 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
NA |
| NCT00294671 |
The Effect of Diflunisal on Familial Amyloidosis |
https://ClinicalTrials.gov/show/NCT00294671 |
Completed |
Boston University |
2012-12-31 |
| NCT00289497 |
TempTouch IR Thermometry & Diabetic Patient Self-Care |
https://ClinicalTrials.gov/show/NCT00289497 |
Completed |
Diabetica Solutions Inc. |
NA |
| NCT00286260 |
Levetiracetam for Painful Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00286260 |
Completed |
Odense University Hospital |
2008-08-31 |
| NCT00278980 |
Effect of C-Peptide on Diabetic Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT00278980 |
Completed |
Creative Peptides Sweden Inc. |
NA |
| NCT00278629 |
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00278629 |
Active, not recruiting |
Northwestern University |
2019-07-31 |
| NCT00259974 |
RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
https://ClinicalTrials.gov/show/NCT00259974 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-01-31 |
| NCT00231673 |
A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00231673 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00220740 |
Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
https://ClinicalTrials.gov/show/NCT00220740 |
Completed |
Grifols Therapeutics LLC |
2006-06-30 |
| NCT00162968 |
Escitalopram as a Treatment for Pain in Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00162968 |
Completed |
Odense University Hospital |
NA |
| NCT00156689 |
A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy. |
https://ClinicalTrials.gov/show/NCT00156689 |
Completed |
Vanderbilt University |
NA |
| NCT00105755 |
Dermal Thermometry and Self-Care of High Risk Diabetic Patients |
https://ClinicalTrials.gov/show/NCT00105755 |
Completed |
VA Office of Research and Development |
NA |
| NCT00101426 |
Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00101426 |
Completed |
Sumitomo Dainippon Pharma Co., Ltd. |
NA |
| NCT00082316 |
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT00082316 |
Completed |
NeurogesX |
NA |
| NCT00001287 |
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
https://ClinicalTrials.gov/show/NCT00001287 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00050245 |
Rituximab to Treat Neuropathy With Anti-MAG Antibodies |
https://ClinicalTrials.gov/show/NCT00050245 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |